Drugs / IDX320
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01157104 | Jun → Jul 2010 | chronic hepatitis C virus infection | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IDX320 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01157104 ↗ |
| Route | Oral | “administered orally once daily” NCT01157104 ↗ |